Relay Therapeutics is trading at $18.53 (-4.73%) amid broader weakness in the biotech sector, following a strong +5.88% close on July 30, 2026.
- The decline tracks a 3.15% drop in the XBI biotech index as risk appetite for growth assets fades across the market.
- There are no company-specific announcements, earnings updates, or analyst actions to explain today's price movement.